格爾軟件(603232.SH):首次公開發行股票募投項目結項 節餘募集資金永久補充流動資金
格隆匯 12 月 29日丨格爾軟件(603232.SH)公佈,此次結項的募投項目名稱:基於PKI的應用安全支撐平台產業化項目、高性能身份管理系統技術升級改造項目、移動安全管理平台產業化項目和技術研發中心擴建項目。
募投項目結項後節餘募集資金安排:公司擬將節餘募集資金人民幣1611.26萬元(包括現金管理收益和利息收入,實際金額以資金轉出當日專户餘額為準)永久性補充流動資金。
該事項已經公司第七屆董事會第十五次會議、第七屆監事會第十一次會議審議通過,無需提交股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.